Published in Naunyn Schmiedebergs Arch Exp Pathol Pharmakol on January 01, 1968
Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog. Br J Pharmacol (1974) 1.00
Inhibition of the re-uptake of neuronally liberated noradrenaline and alpha-receptor blocking action of some ergot alkaloids. Br J Pharmacol (1970) 0.91
Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141). Arzneimittelforschung (1975) 2.72
The effect of indomethacin on the release of prostaglandin E2 and acetylcholine from guinea-pig isolated ileum at rest and during field stimulation. Br J Pharmacol (1974) 2.04
DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.50
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Clin Oncol (1997) 1.20
Trapping and intramyocardial distribution of microspheres with different diameters in cat and rabbit hearts in vitro. Basic Res Cardiol (1982) 0.99
[Comparative studies on the influencing of adrenergic reactions by ergotamine and dihydroergotamine in different experimental models]. Helv Physiol Pharmacol Acta (1968) 0.96
Inhibitory effects of clonidine and BS 100-141 on responses to sympathetic nerve stimulation in cats and rabbits. Br J Pharmacol (1975) 0.93
Inhibition of the re-uptake of neuronally liberated noradrenaline and alpha-receptor blocking action of some ergot alkaloids. Br J Pharmacol (1970) 0.91
Sprouting and nerve retraction in frog neuromuscular junction during ontogenesis and environmental changes. Neuroscience (1986) 0.86
Proceedings: The effect of PGE1, PGE2 and PGF2alpha on parasympathetic transmission. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.86
Pharmacological actions of APP 201-533, a novel cardiotonic agent. J Cardiovasc Pharmacol (1985) 0.84
[Bicyclic 3-hydrazinopyridazines with antihypertensive action (author's transl)]. Arzneimittelforschung (1979) 0.84
Effects of age and smoking on the pharmacokinetics of pindolol and propranolol. Br J Clin Pharmacol (1982) 0.83
[Antipsychotic efficacy in relation to plasma levels of clozapine (author's transl)]. Arzneimittelforschung (1976) 0.83
Interaction of DPI 201-106 with cardiac glycosides. J Cardiovasc Pharmacol (1989) 0.81
Cardiovascular actions of DPI 201-106, a novel cardiotonic agent. J Cardiovasc Pharmacol (1986) 0.81
Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart. Am J Cardiol (1987) 0.81
A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet. Eur J Clin Pharmacol (1981) 0.79
[Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)]. Arzneimittelforschung (1979) 0.79
[Pharmacology, pharmacokinetics and toxicology of the new antihistaminic HS 592 (Tavegil)]. Boll Chim Farm (1967) 0.78
Computer-aided calculation of the molecular size of nondenatured proteins in pore-gradient gel electrophoresis. Electrophoresis (1991) 0.78
Digoxin-specific antibody fragments and a calcium antagonist for reversal of digoxin-induced mesenteric vasoconstriction. J Pharm Pharmacol (1983) 0.77
Pharmacologic studies on the structure-activity relationship of hydroxyindole alkylamines. Adv Pharmacol (1968) 0.76
The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats. J Pharm Pharmacol (1979) 0.76
Regional differences in the responsiveness of isolated arteries from cattle, dog and man. Agents Actions (1977) 0.76
Measurement of free concentration of SDZ ICM 567 in blood and muscle using microdialysis sampling. Biopharm Drug Dispos (1995) 0.76
Pharmacological actions of SDZ 218-135, a novel positive inotropic agent. Cardiovasc Drugs Ther (1994) 0.75
The effects of the beta-adrenoceptor blocking agent LL 21-945 on renal hypertensive (Grollman) rats. Arch Int Pharmacodyn Ther (1976) 0.75
Determination of SDZ ICM 567 in blood and muscle microdialysis samples by microbore liquid chromatography with ultraviolet and fluorescence detection. J Chromatogr B Biomed Sci Appl (1997) 0.75
[Influence of ergotamine on humoral and neuronal effects in the cat nictitating membrane and spleen]. Helv Physiol Pharmacol Acta (1967) 0.75
[Pharmacological studies on the new antihistaminic Tavegil]. Med Welt (1966) 0.75
[Aminoalcohol esters of hydroxyboranes. 10. Tetracycline boron Mannich bases as potential antineoplastic agents]. Arch Pharm (Weinheim) (1984) 0.75
[Relationships between effects and plasma levels of clozapine (author's transl)]. Arzneimittelforschung (1978) 0.75
[On the pharmacology of psychotropic drugs used in child psychiatry]. Ser Paedopsychiatr (1965) 0.75
[Pharmacological, pharmacokinetic and toxicological research on mesoridazine (NC 123)]. Boll Chim Farm (1967) 0.75
[The pharmacological evaluation of drugs]. Pharm Acta Helv (1968) 0.75
[Extrarenal effects of a salidiuretic]. Arzneimittelforschung (1966) 0.75
Pharmacological differentiation of sedative drugs. Electroencephalogr Clin Neurophysiol (1969) 0.75
An automated fluorimetric method for the determination of fluproquazone in plasma and urine. Arzneimittelforschung (1981) 0.75
Animal studies with topical steroids. Acta Derm Venereol Suppl (Stockh) (1973) 0.75
Effect of food intake on plasma levels and antihypertensive response during maintenance therapy with endralazine. Eur J Clin Pharmacol (1987) 0.75
[Cognitive and psychomotor performance following isoflurane, midazolam/alfentanil and propofol anesthesia. A comparative study]. Anaesthesist (1992) 0.75
[Pharmacological properties of acetyldigoxin-alpha]. Schweiz Med Wochenschr (1966) 0.75
[Pharmacologic and clinical properties of a new butyrophenone derivative (FR 33)]. Psychopharmacologia (1966) 0.75
Heart failure and Ca++ activation of the cardiac contractile system: hereditary cardiomyopathy in hamsters (BIO 14.6), isoprenaline overload and the effect of APP 201-533. Basic Res Cardiol (1987) 0.75
[Derivatives of D-glucosamine. 12. Reactions of 2-acylamido-1,3,4,6-tetra-o-benzoyl-2-desocy-alpha-D-glucopyranoses with hydrogen bromide]. Carbohydr Res (1973) 0.75
[The problem of toxicity in pharmaceutical industries]. Bibl Tuberc (1969) 0.75
Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs. J Pharm Pharmacol (1983) 0.75
[The effect of tricyclic antidepressants on rabbit 5-hydroxytryptophan hyperthermia]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1966) 0.75
[Pharmacologic differentiation of sedatives]. Rev Neurol (Paris) (1969) 0.75
Influence of smoking and age on pharmacokinetics of beta-receptor blockers. Gerontology (1982) 0.75
Determination of a novel xanthine derivative, MKS 213-492, in plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl (1995) 0.75
Pharmacokinetic comparison of pindolol 30 mg retard and 15 mg normal tablets. Eur J Clin Pharmacol (1982) 0.75
[The action of ergotamine on humoral and neuronal effects in the nictitating membrane of the cat]. Helv Physiol Pharmacol Acta (1966) 0.75
The effects of ergot compounds on the release of noradrenaline and prostaglandins from the isolated perfused cat spleen during nerve stimulation. Postgrad Med J (1976) 0.75